CAS: 7795-95-1; Octane-1-Sulfonyl Chloride

该化合物是一种有机化合物,其特点是附于辛烷链的全氟辛烷磺酸功能组;它是一种无色的,一般用作有机合成试剂的黄色液体,特别是用于制作磺酰胺和其他磺酰衍生物的;该化合物以其强烈的电益特性而著称,使它对核素反应高度;由于存在促成其极地特性的磺酰基组,它有一个相对较高的沸点.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号111-88-6 1-辛硫醇 | CAS号19942-78-0 硫氰酸辛酯 | CAS号822-27-5 二正辛基二硫 | CAS号69422-58-8 S,S-di°Ctyl dit... | CAS号5324-84-5 1-辛基磺酸钠 | CAS号3944-72-7 辛基磺酸 | CAS号85293-39-6 °Ctylsulfanylme... | CAS号111-83-1 1-溴代正辛烷 | CAS号307-34-6 全氟辛烷 | CAS号307-35-7 全氟辛基磺酰氟 | CAS号423-60-9 全氟辛烷磺酰氯 | CAS号872-05-9 正癸烯 | CAS号111-85-3 氯辛烷 | CAS号629-27-6 1-碘辛烷 | CAS号10307-28-5 methyl °Ctanesu... | CAS号104-72-3 癸基苯 | CAS号2189-60-8 正辛基苯 | CAS号3307-19-5 4-°Ctylanisole

合成工艺路线路线简述

  • 合成目标产物 1-Octanesulfonyl Chloride 主要起始原料 Carbamimidothioic Acid,Octyl Ester, Monohydrobromide (9CI)
  • (文献来源)合成步骤主要原料 Carbamimidothioic Acid,Octyl Ester, Monohydrobromide (9Ci)
1-辛硫醇置于双氧水,氯化锆(Iv)体系中,用 水,乙腈 作为反应溶剂,化学反应 0.03H,以95%的收率获得产物1-辛烷磺酰氯
参考文献:从硫醇和二硫化物衍生物中新型实用合成磺酰氯
标题:从硫醇和二硫化物衍生物中新型实用合成磺酰氯
摘要:在四氯化锆的存在下,过氧化氢是一种非常有效的试剂,可通过氧化氯化将硫醇和二硫化物衍生物直接氧化转化为相应的高纯度磺酰氯.优异的收率,极短的反应时间,温和的反应条件以及避免使用刺激性试剂是该方法的主要优点.
DOI:10.1055/s-0029-1217989

海关参考信息

专利信息


专利号:US-6228988-B1
优先权日:1995-02-24
标题:Synthesis of hydroxamic acid derivatives
发明人:FLOYD CHRISTOPHER DAVID; LEWIS CHRISTOPHER NORMAN
权利人:BRITISH BIOTECH PHARM
摘要:The present invention describes processes for preparing desired synthetic products that comprise a covalently bonded hydroxamic acid group -CONHOH by forming a mixture of a liquid reaction medium and a solid phase reaction product that carries a plurality of moieties of formula (A1) or (B1):where X is a residual, non-hydroxamate partial structure of the desired synthetic product, P1 is hydrogen or an amino-protecting group, P2 is hydrogen or a hydroxyl protecting group, and the bond designated (a) covalently links the moieties (A1) or (B1) to the residue of a solid substrate; by cleaving the bond designated (a) in the resultant mixture; and by separating the resultant liquid reaction phase from the resultant reaction solids to recover the desired synthetic product.

专利号:US-12227522-B2
优先权日:2020-12-21
标题:Synthesis of structural analogs of largazole and associated compounds
发明人:WILLIAMS ROBERT M; KOTI SIVANAGIREDDY; DE SUBHADIP; SHELKE ANIL M; CERBONE RYAN E; YASUDA NOBUYOSHI
权利人:UNIV COLORADO STATE RES FOUND; CETYA THERAPEUTICS INC
摘要:Disclosed are various synthetic methods to prepare structural analogs of largazole and derivatives thereof. One structural analog is an amide isostere of largazole. Another structural analog replaces the thiazole ring of largazole with a pyridine moiety or an oxazole moiety. Also disclosed are various intermediate compounds obtained when preparing structural analogs of largazole and derivatives thereof, including macrocycle analogs having an alcohol functionality.

专利号:US-2005192265-A1
优先权日:2003-03-20
标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-6906056-B2
优先权日:1998-06-22
标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
权利人:LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-6093798-A
优先权日:1995-02-24
标题 :Synthesis of hydroxamic acid derivatives

专利号:WO-2010115869-A1
优先权日:2009-04-03
标 题 :Propofol phosphonyl derivatives, synthesis, and use in long acting formulations
发明人:GONNISSEN YVES RENE JOHANNA PAUL
权利人:SEPS PHARMA N V; GONNISSEN YVES RENE JOHANNA PAUL
摘要:This invention relates to compounds represented by the structural formula (I), and the salts and stereoisomers thereof, wherein: - L is a linker selected from the group consisting of -(CH 2 ) P -O-, a single bond, formula (IA), -(CH 2 ) 1-8 -O-X(O)-, and - p is an integer from 1 to 8, - each R 3 and each R 4 is independently selected from the group consisting of C 1-20 alkyl, C 3-12 alkyl, C 3-12 cycloalkyl-C 1-4 alkyl, saturated heterocyclyl and saturated heterocyclyl-C 1-4 alkyl, and - X and Y are each independently C or S(O), - Z is selected from the group consisting of O, S(O) and NR 5 , - W is selected from the group consisting of halogen, OH, S(O)H and O - M + wherein M + is a monovalent cation; and - R 5 is selected from the group consisting of hydrogen and C 1-10 alkyl. These compounds are useful pharmaceutical agents with improved oral bioavailability.
杭州奥泰化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.alltechchem.com
电话: 0571-86739500👤
📞杭州奥泰化工有限公司 ⚠️参考联系方式

销售电话:0571-86739500
邮箱:sales@alltechchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
江西国化医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.groupchem.com
企业联系电话:+86-794-7183888👤
📞江西国化医药科技有限公司 ⚠️参考联系方式
联系人:陈先生 王小姐
电话:+86-794-7183888
手机:+86-13867635890
传真:+86-794-5269668
邮箱:sales@groupchem.com
通信地址: 江西省抚州市抚州高新技术产业开发区洋浦香精以东,科纵三路以西
邮编: 318000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江西省抚州市抚州高新技术产业开发区洋浦香精以东,科纵三路以西
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kostikov, R. R.; Khlebnikov, A. F.; Sokolov, V. V., Science of Synthesis, (2010) 47, 844.
摘要:Witt, D., Science of Synthesis Knowledge Updates, (2011) 3, 242.
摘要:Łyżwa, P., Science of Synthesis Knowledge Updates, (2011) 2, 486.
摘要:Łyżwa, P., Science of Synthesis Knowledge Updates, (2011) 2, 475.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知